Marijuana stock GW Pharmaceuticals lands least-restrictive DEA schedule
GW Pharmaceuticals gained an advantage over Tilray with DEA scheduling of Epidiolex on Thursday. Publicly traded GW Pharmaceuticals had a monumental win on Thursday. The company’s cannabis-derived epilepsy drug, Epidiolex,